Neurokinetic S.A.S. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Offices of Other Health Practitioners industry. It was incorporated on October 21, 2022. There are currently 2 (2024) people employed by Neurokinetic S.A.S.. There was a net sales revenue increase of 99.03% reported in Neurokinetic S.A.S.’s latest financial highlights for 2025. Its total assets grew by 15.45% over the same period. The net profit margin of Neurokinetic S.A.S. increased by 13.06% in 2025.

Headquarters
Calle Crotos y Av. Rodolfo Baquerizo Naz, 0635
Guayaquil; Guayas;

Contact Details: Purchase the Neurokinetic S.A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Neurokinetic S.A.S. report to view the information.

Registered Capital:

Purchase the Neurokinetic S.A.S. report to view the information.

Financial Auditors:

Purchase the Neurokinetic S.A.S. report to view the information.

Incorporation Date:

October 21, 2022

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Neurokinetic S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

99.03%▲

Total Operating Revenue

99.03%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

10649.69%▲

Total Assets

15.45%▲

Total Equity

192.44%▲

Operating Profit Margin

N/A

Net Profit Margin

13.06%▲

Return on Equity (ROE)

57.61%▲

Quick Ratio

6.88%▲

Cash Ratio

4.53%▲

Neurokinetic S.A.S. (Ecuador)